Soleno Therapeutics Inc SLNO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
43.50UNCH (UNCH)
Volume
7,245
Close
43.50quote price arrow up+0.70 (+1.64%)
Volume
212,173
52 week range
3.69 - 53.82
Loading...
  • Open42.87
  • Day High44.34
  • Day Low42.75
  • Prev Close42.80
  • 52 Week High53.82
  • 52 Week High Date02/28/24
  • 52 Week Low3.69
  • 52 Week Low Date09/07/23

Key Stats

  • Market Cap1.508B
  • Shares Out34.68M
  • 10 Day Average Volume0.58M
  • Dividend-
  • Dividend Yield-
  • Beta-1.39
  • YTD % Change8.07

KEY STATS

  • Open42.87
  • Day High44.34
  • Day Low42.75
  • Prev Close42.80
  • 52 Week High53.82
  • 52 Week High Date02/28/24
  • 52 Week Low3.69
  • 52 Week Low Date09/07/23
  • Market Cap1.508B
  • Shares Out34.68M
  • 10 Day Average Volume0.58M
  • Dividend-
  • Dividend Yield-
  • Beta-1.39
  • YTD % Change8.07

RATIOS/PROFITABILITY

  • EPS (TTM)-2.68
  • P/E (TTM)-16.23
  • Fwd P/E (NTM)-20.46
  • EBITDA (TTM)-54.432M
  • ROE (TTM)-71.26%
  • Revenue (TTM)-
  • Gross Margin (TTM)100.00%
  • Net Margin (TTM)-3,700.69%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Soleno Therapeutics Inc

 

Profile

MORE
Soleno Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate, Diazoxide Choline Extended-Release tablets (DCCR), extended-release tablets, a once-daily oral tablet for the treatment of Prader-Willi syndrome (PWS), recently completed its Phase 3 development program. DCCR is a potent ATP-sensitive potassium (KATP) channel...
Ernest Mario Ph.D.
Independent Chairman of the Board
Anish Bhatnagar M.D.
President, Chief Executive Officer, Chief Operating Officer, Director
James Mackaness
Chief Financial Officer
Kristen Yen
Vice President - Clinical Operations
Dairine Dempsey Ph.D.
Vice President - Europe
Address
203 Redwood Shores Parkway, Suite 500
Redwood City, CA
94065
United States

Top Peers

SYMBOLLASTCHG%CHG
KURA
Kura Oncology Inc
20.91+0.30+1.46%
SANA
Sana Biotechnology Inc
8.60+0.69+8.72%
MORF
Morphic Holding Inc
28.36-0.32-1.12%
EWTX
Edgewise Therapeutics Inc
17.44-0.04-0.23%
AKRO
Akero Therapeutics Inc
20.30-0.32-1.55%